Literature DB >> 27793677

Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3.

Celso E Gomez-Sanchez1, Xin Qi2, Elise P Gomez-Sanchez3, Hironobu Sasano4, Martin O Bohlen5, Max Wisgerhof6.   

Abstract

Three forms of familial primary aldosteronism have been recognized. Familial Hyperaldosteronism type 1 (FH1) or dexamethasone suppressible hyperaldosteronism, FH2, the most common form of as yet unknown cause(s), and FH3. FH3 is due to activating mutations of the potassium channel gene KCNJ5 that increase constitutive and angiotensin II-induced aldosterone synthesis. In this study we examined the cellular distribution of CYP11B2, CYP11B1, CYP17A1 and KCNJ5 in adrenals from two FH3 siblings using immunohistochemistry and immunofluorescence and obtained unexpected results. The adrenals were markedly enlarged with loss of zonation. CYP11B2 was expressed sporadically throughout the adrenal cortex. CYP11B2 was most often expressed by itself, relatively frequently with CYP17A1, and less frequently with CYP11B1. KCNJ5 was co-expressed with CYP11B2 and in some cells with CYP11B1. This aberrant co-expression of enzymes likely explains the abnormally high secretion rate of the hybrid steroid, 18-oxocortisol. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Aldosterone; CYP11B2; CYP17A1; KCNJ5; Primary aldosteronism

Mesh:

Substances:

Year:  2016        PMID: 27793677      PMCID: PMC5123946          DOI: 10.1016/j.mce.2016.10.025

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  30 in total

1.  [Constitution of aldosterone, a new mineralocorticoid].

Authors:  S A SIMPSON; J F TAIT; A WETTSTEIN; R NEHER; J VON EUW; O SCHINDLER; T REICHSTEIN
Journal:  Experientia       Date:  1954-03-15

2.  [Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism].

Authors:  S A SIMPSON; J F TAIT; A WETTSTEIN; R NEHER; J VON EUW; T REICHSTEIN
Journal:  Experientia       Date:  1953-09

3.  Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.

Authors:  Ute I Scholl; Carol Nelson-Williams; Peng Yue; Roger Grekin; Robert J Wyatt; Michael J Dillon; Robert Couch; Lisa K Hammer; Frances L Harley; Anita Farhi; Wen-Hui Wang; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

4.  Isolation of a highly active mineralocorticoid from beef adrenal extract.

Authors:  H M GRUNDY; S A SIMPSON; J F TAIT
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

5.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

6.  Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.

Authors:  M Stowasser; R D Gordon; T J Tunny; S A Klemm; W L Finn; A L Krek
Journal:  Clin Exp Pharmacol Physiol       Date:  1992-05       Impact factor: 2.557

Review 7.  New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.

Authors:  Ute I Scholl; Richard P Lifton
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

8.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

9.  The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-07-13       Impact factor: 4.736

10.  Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension.

Authors:  S Ulick; M D Chu
Journal:  Clin Exp Hypertens A       Date:  1982
View more
  8 in total

Review 1.  Familial hyperaldosteronism type III a novel case and review of literature.

Authors:  Natividad Pons Fernández; Francisca Moreno; Julia Morata; Ana Moriano; Sara León; Carmen De Mingo; Ángel Zuñiga; Fernando Calvo
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 2.  Familial hyperaldosteronism type III.

Authors:  S Monticone; M Tetti; J Burrello; F Buffolo; R De Giovanni; F Veglio; T A Williams; P Mulatero
Journal:  J Hum Hypertens       Date:  2017-04-27       Impact factor: 3.012

Review 3.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

4.  18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.

Authors:  Yuta Tezuka; Yuto Yamazaki; Masaaki Kitada; Ryo Morimoto; Masataka Kudo; Kazumasa Seiji; Kei Takase; Yoshihide Kawasaki; Koji Mitsuzuka; Akihiro Ito; Jun Nishikawa; Noriko Asai; Yasuhiro Nakamura; Celso E Gomez-Sanchez; Sadayoshi Ito; Mari Dezawa; Hironobu Sasano; Fumitoshi Satoh
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

Review 5.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

6.  Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study.

Authors:  Nae Takizawa; Susumu Tanaka; Koshiro Nishimoto; Yuki Sugiura; Makoto Suematsu; Chisato Ohe; Haruyuki Ohsugi; Yosuke Mizuno; Kuniaki Mukai; Tsugio Seki; Kenji Oki; Celso E Gomez-Sanchez; Tadashi Matsuda
Journal:  Curr Issues Mol Biol       Date:  2021-12-28       Impact factor: 2.976

7.  Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.

Authors:  Zeng Guo; Kazutaka Nanba; Aaron Udager; Brett C McWhinney; Jacobus P J Ungerer; Martin Wolley; Moe Thuzar; Richard D Gordon; William E Rainey; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 8.  Molecular Mechanisms of Primary Aldosteronism.

Authors:  Sergei G Tevosian; Shawna C Fox; Hans K Ghayee
Journal:  Endocrinol Metab (Seoul)       Date:  2019-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.